Stephan Moll, MD writes…
The CDC published an alert on Oct 26th, 2012, that they are investigating 12 cases of TTP (thrombotic thrombocytopenic purpura) in drug users who injected intravenously the opioid pain medication Opana ER® (oxymorphone extended-release), a medication made as a tablet and meant for oral use. The tablet was pulverized by the drug users to allow i.v. injection (detailed CDC alert here).
Relevance for clinicans involved in the care of patients with TTP: Inquire in the history taking about drug abuse and injection of Opana ER.
Last updated: Oct 29th, 2012